Multiple high-grade gliomas: epidemiology, management, and outcome. A systematic review and meta-analysis
- PMID: 29138949
- DOI: 10.1007/s10143-017-0928-7
Multiple high-grade gliomas: epidemiology, management, and outcome. A systematic review and meta-analysis
Abstract
Multiple high-grade gliomas (M-HGGs) are well--separated tumors, differentiated as multifocal (MF) and multicentric (MC) by their MRI features. The authors performed a systematic review and meta-analysis of literature examining epidemiology, clinical and radiological characteristics, management, and the overall survival from M-HGGs. According to PRISMA guidelines, a comprehensive review of studies published between January 1990 and January 2017 was carried out. The authors identified studies that examined the prevalence rate, clinical and radiological characteristics, treatment, and overall survival from M-HGGs in patients with HGG. Data were analyzed using a random-effects meta-analysis model. Finally, we systematically reviewed demographic characteristics, lesion location, and surgical and adjuvant treatments. Twenty-three studies were included in this systematic review. The M-HGGs prevalence rate was 19% (95% CI 13-26%) and the hazard ratio of death from M-HGGs in the HGGs population was 1.71 (95% CI 1.49-1.95, p < 0.0001). The MC prevalence rate was 6% (CI 95% 4-10%), whereas MF prevalence rate was 11% (CI 95% 6-20%) (p < 0.0001). There were no statistically significant differences between MF and MC HGGs in gender, lesion location, histological type, and surgical treatment. Survival analysis of MC tumors showed that surgical resection (gross total resection or subtotal resection) is an independent predictor of improved outcome (HR 7.61 for biopsy subgroup, 95% CI 1.94-29.78, p = 0.004). The prevalence of M-HGGs is approximately 20% of HGGs. The clinical relevance of separating M-HGGs in MF and MC tumors remains questionable and its prognostic significance is unclear. When patient status and lesion characteristics make it safe and feasible, cytoreduction should be attempted in patients with M-HGGs because it improves overall survival.
Keywords: Glioblastoma; High-grade glioma; Multicentric; Multifocal; Multiple cerebral lesions; Systematic review.
Similar articles
-
IDH wild-type WHO grade II diffuse low-grade gliomas. A heterogeneous family with different outcomes. Systematic review and meta-analysis.Neurosurg Rev. 2020 Apr;43(2):383-395. doi: 10.1007/s10143-018-0996-3. Epub 2018 Jun 26. Neurosurg Rev. 2020. PMID: 29943141
-
Insular glioma resection: assessment of patient morbidity, survival, and tumor progression.J Neurosurg. 2010 Jan;112(1):1-9. doi: 10.3171/2009.6.JNS0952. J Neurosurg. 2010. PMID: 19612970
-
Survival of Ventricular and Periventricular High-Grade Gliomas: A Surveillance, Epidemiology, and End Results Program-Based Study.World Neurosurg. 2018 Mar;111:e323-e334. doi: 10.1016/j.wneu.2017.12.052. Epub 2017 Dec 16. World Neurosurg. 2018. PMID: 29258929
-
Is It Worth Considering Multicentric High-Grade Glioma a Surgical Disease? Analysis of Our Clinical Experience and Literature Review.Tomography. 2021 Oct 5;7(4):523-532. doi: 10.3390/tomography7040045. Tomography. 2021. PMID: 34698304 Free PMC article. Review.
-
Volumetric Analysis of Extent of Resection, Survival, and Surgical Outcomes for Insular Gliomas.World Neurosurg. 2017 Jul;103:265-274. doi: 10.1016/j.wneu.2017.04.002. Epub 2017 Apr 10. World Neurosurg. 2017. PMID: 28408263
Cited by
-
Plumeria alba-Mediated Green Synthesis of Silver Nanoparticles Exhibits Antimicrobial Effect and Anti-Oncogenic Activity against Glioblastoma U118 MG Cancer Cell Line.Nanomaterials (Basel). 2022 Jan 30;12(3):493. doi: 10.3390/nano12030493. Nanomaterials (Basel). 2022. PMID: 35159838 Free PMC article.
-
The Clinical Significance and Transcription Regulation of a DNA Damage Repair Gene, SMC4, in Low-Grade Glioma via Integrated Bioinformatic Analysis.Front Oncol. 2021 Nov 11;11:761693. doi: 10.3389/fonc.2021.761693. eCollection 2021. Front Oncol. 2021. PMID: 34868977 Free PMC article.
-
Glioblastoma under Siege: An Overview of Current Therapeutic Strategies.Brain Sci. 2018 Jan 16;8(1):15. doi: 10.3390/brainsci8010015. Brain Sci. 2018. PMID: 29337870 Free PMC article. Review.
-
Repurposing FDA approved drugs inhibiting mitochondrial function for targeting glioma-stem like cells.Biomed Pharmacother. 2021 Jan;133:111058. doi: 10.1016/j.biopha.2020.111058. Epub 2020 Dec 8. Biomed Pharmacother. 2021. PMID: 33378970 Free PMC article.
-
Two Patterns of White Matter Connection in Multiple Gliomas: Evidence from Probabilistic Fiber Tracking.J Clin Med. 2022 Jun 27;11(13):3693. doi: 10.3390/jcm11133693. J Clin Med. 2022. PMID: 35806978 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical